Pharmaceutical Research and Manufacturers of America v. Stolfi

Why this Matters:

The plaintiffs argue that an Oregon law promoting increased transparency into prescription drug pricing violates the Takings Clause of the Fifth Amendment and the First Amendment. Transparency laws that require manufacturers to justify drug pricing increases are one approach states are currently pursuing to lower prescription drug costs for their residents.

Potential Impact:

The inability for state policymakers to address prescription drug affordability could negate savings for patients, and more broadly restrict state regulatory authority in the health care arena.